CURIS director receives 6,800 stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CURIS INC director Anne Elizabeth Borgman received a grant of non-qualified stock options, acquiring rights to purchase 6,800 shares of common stock at an exercise price of $5.29 per share. These options vest 100% on July 7, 2027 and expire on July 6, 2036. Following this grant, her reported derivative holdings from this award total 6,800 options, reflecting compensation-related equity rather than an open-market purchase.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non Qualified Stock Option | 6,800 | $5.29 | $36K |
Footnotes (1)
- F1. The option grant described in this Form 4 filing vests as to 100% of the underlying shares on July 7, 2027.
Key Figures
Key Terms
Non Qualified Stock Option financial
vesting financial
exercise price financial
expiration date financial
underlying security financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CURIS INC (CRIS) director Anne Borgman report in this Form 4?
How many CURIS INC (CRIS) options were granted to Anne Borgman and at what price?
When do Anne Borgman’s CURIS INC (CRIS) stock options vest and expire?
Are Anne Borgman’s CURIS INC (CRIS) option transactions open-market buys or compensation?
How many CURIS INC (CRIS) options does Anne Borgman hold after this grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.